Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Shares Cross Above Two Hundred Day Moving Average – What’s Next?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $23.13 and traded as high as $23.92. Fresenius Medical Care AG & Co. KGaA shares last traded at $23.43, with a volume of 787,068 shares trading hands.

Analyst Ratings Changes

FMS has been the topic of a number of analyst reports. Jefferies Financial Group upgraded Fresenius Medical Care AG & Co. KGaA from a “strong sell” rating to a “moderate sell” rating in a research note on Friday, May 8th. Sanford C. Bernstein upped their price target on shares of Fresenius Medical Care AG & Co. KGaA from $25.50 to $25.80 and gave the stock a “market perform” rating in a research report on Thursday, August 6th. Morgan Stanley reissued an “underweight” rating on shares of Fresenius Medical Care AG & Co. KGaA in a research report on Wednesday, May 6th. Truist Financial set a $25.00 target price on shares of Fresenius Medical Care AG & Co. KGaA in a report on Wednesday, August 5th. Finally, Citigroup reiterated a “neutral” rating on shares of Fresenius Medical Care AG & Co. KGaA in a report on Friday, July 17th. Six equities research analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Reduce” and an average price target of $23.57.

Fresenius Medical Care AG & Co. KGaA Stock Performance

The company has a market cap of $12.58 billion, a price-to-earnings ratio of 12.14, a PEG ratio of 4.35 and a beta of 0.77. The company has a current ratio of 1.07, a quick ratio of 0.75 and a debt-to-equity ratio of 0.43. The business’s 50 day moving average price is $23.96 and its 200-day moving average price is $23.13.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) last announced its quarterly earnings results on Monday, August 3rd. The company reported $0.66 EPS for the quarter, beating analysts’ consensus estimates of $0.62 by $0.04. Fresenius Medical Care AG & Co. KGaA had a net margin of 4.83% and a return on equity of 9.28%. The business had revenue of $5.55 billion for the quarter, compared to analyst estimates of $5.48 billion. On average, equities analysts anticipate that Fresenius Medical Care AG & Co. KGaA will post 2.25 EPS for the current fiscal year.

Institutional Trading of Fresenius Medical Care AG & Co. KGaA

Several institutional investors have recently added to or reduced their stakes in the company. Morgan Stanley increased its position in Fresenius Medical Care AG & Co. KGaA by 47.2% during the 4th quarter. Morgan Stanley now owns 2,939,839 shares of the company’s stock worth $70,027,000 after buying an additional 942,497 shares during the period. Pzena Investment Management LLC increased its position in Fresenius Medical Care AG & Co. KGaA by 2.0% during the first quarter. Pzena Investment Management LLC now owns 15,052,822 shares of the company’s stock worth $339,592,000 after acquiring an additional 299,986 shares during the period. Bank of America Corp DE increased its position in Fresenius Medical Care AG & Co. KGaA by 279.7% during the second quarter. Bank of America Corp DE now owns 337,316 shares of the company’s stock worth $9,637,000 after acquiring an additional 248,477 shares during the period. ABC Arbitrage SA raised its stake in Fresenius Medical Care AG & Co. KGaA by 1,136.0% in the 4th quarter. ABC Arbitrage SA now owns 249,800 shares of the company’s stock worth $5,950,000 after purchasing an additional 229,589 shares in the last quarter. Finally, Integral Health Asset Management LLC raised its stake in Fresenius Medical Care AG & Co. KGaA by 44.4% in the 4th quarter. Integral Health Asset Management LLC now owns 650,000 shares of the company’s stock worth $15,483,000 after purchasing an additional 200,000 shares in the last quarter. 8.37% of the stock is currently owned by institutional investors.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA is the world’s largest integrated provider of products and services for individuals with renal diseases. The company’s primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services.

In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high‐flux dialyzers and bloodlines.